Dae Won Jun

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

Medicine, Internal Medicine, Pharmacotherapy +12

Clinical implications of fatty pancreas: Correlations between fatty pancreas and metabolic syndrome

Jun Seok Lee, Sang Heum Kim, Dae Won Jun et al. · World Journal of Gastroenterology · 2009 · 308 citations · Full text

Medicine, Endocrinology, Pathology +17

Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States

Michael H. Le, Pardha Devaki, Nghiem B. Ha et al. · PLoS ONE · 2017 · 292 citations · Full text

Medicine, Internal Medicine, Epidemiology +15

KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease

Seong Hee Kang, Hye Won Lee, Jeong‐Ju Yoo et al. · Clinical and Molecular Hepatology · 2021 · 265 citations · Full text

Medicine, Internal Medicine, Gastroenterology +12

FXR Inhibits Endoplasmic Reticulum Stress-Induced NLRP3 Inflammasome in Hepatocytes and Ameliorates Liver Injury

Chang Yeob Han, Hyun Soo Rho, Ayoung Kim et al. · Cell Reports · 2018 · 228 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17